Atherosclerotic calcification is the buildup of calcium deposits inside artery walls, driven by the same chronic inflammatory process that forms fatty plaques. Far from being a passive side effect of aging, research shows it is an actively regulated biological process in which cells within the vessel wall transform and begin behaving like bone-forming cells. The presence and pattern of this calcification carries real information about heart attack risk, but the relationship is less straightforward than “more calcium equals more danger.” The size, density, and location of calcium deposits all matter, and some forms of calcification may actually make a plaque more stable rather than less.
How Calcium Ends Up in Your Arteries
For decades, vascular calcification was written off as a late, inevitable consequence of atherosclerosis, something that just happened when plaques got old enough. That view has been overturned. Calcification is now understood to be an active process driven in part by smooth muscle cells in the artery wall that essentially change careers: they stop acting like muscle cells and start acting like bone or cartilage cells, laying down mineral deposits the way bones do during growth and repair.1Oxford Academic. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness This transformation is triggered by signals from the local environment, including inflammation, oxidized lipids, and changes in calcium and phosphate levels in the blood.
The process shares an unsettling number of features with normal bone formation. The same proteins that guide mineral deposition in your skeleton show up in calcifying plaques. The difference is that bone formation in your femur is helpful; mineral deposition inside your coronary artery is not. Once this cellular reprogramming begins, it tends to be self-reinforcing. Damaged and dying cells within the plaque release tiny vesicles that serve as seeds for new mineral crystals, so calcification begets more calcification.
Why Size and Density of Calcium Deposits Matter More Than Total Amount
One of the most counterintuitive findings in cardiovascular research is that not all calcification is equally dangerous. In fact, some patterns of calcification appear to stabilize plaques and reduce the chance they will rupture. The critical distinction is between microcalcifications and large, dense sheets of calcium.
Microcalcifications are tiny specks of calcium, often smaller than 50 micrometers, embedded in the thin fibrous cap that covers a plaque. Biomechanical modeling shows that these small deposits act like stress concentrators: they create points of mechanical weakness in the cap, amplifying local strain enough to trigger rupture.2PubMed Central. Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability Think of it like a tiny hard pebble embedded in a stretched rubber sheet. The mismatch in stiffness between the soft tissue and the rigid mineral creates a focal point where tearing is most likely to start. A plaque with scattered microcalcifications in its cap is more vulnerable to rupture than one with no calcification at all.
Large, confluent sheets of calcium, on the other hand, tend to form deeper in the plaque and may actually stiffen it in a way that resists rupture. A heavily calcified plaque is less likely to deform and crack open under the pulsing pressure of blood flow. This is why a very high calcium score on a CT scan does not automatically mean you are about to have a heart attack. It means you have significant atherosclerosis, and that matters for long-term risk, but the morphology of the calcium is what determines short-term danger.
What Drives Calcification Beyond Standard Heart Disease Risk Factors
The usual suspects for atherosclerosis, high blood pressure, high cholesterol, smoking, diabetes, and aging, all accelerate vascular calcification. But certain conditions push it into overdrive through mechanisms that go beyond typical plaque biology.
Chronic kidney disease is the most striking example. When the kidneys lose their ability to regulate mineral balance, blood levels of phosphate rise and the hormonal systems that normally keep calcium and phosphate in check become disrupted. This disordered mineral metabolism is frequently accompanied by bone loss and a dramatic increase in vascular calcification.3PubMed Central. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts In a grim irony, the calcium that should be in your bones ends up in your blood vessels instead. People with advanced kidney disease often have calcification that is far more extensive and appears at younger ages than what you see in the general population, and it is one of the major reasons cardiovascular disease is the leading cause of death in dialysis patients.
Diabetes accelerates calcification through several routes. Chronically elevated blood sugar promotes the kind of oxidative stress and inflammation that triggers smooth muscle cells to transform into mineral-depositing cells. It also damages the small blood vessels that supply the artery wall itself, compounding the injury. Type 2 diabetes and kidney disease frequently coexist, creating a feedback loop where each condition worsens the calcification driven by the other.
Age is the single strongest predictor of coronary calcium, and its effect is not subtle. Calcification is relatively uncommon in people under 40 and nearly universal in people over 70. This reflects both the cumulative exposure to risk factors over a lifetime and the gradual decline in the body’s ability to keep mineral metabolism tightly regulated.
Coronary Artery Calcium Scoring and What the Numbers Mean
A coronary artery calcium (CAC) score is obtained from a low-dose CT scan of the heart that takes about ten minutes, requires no injections or dye, and gives a single number representing the total amount of calcified plaque in your coronary arteries. The Agatston score, named after the cardiologist who developed the method, is the standard unit. A score of zero means no detectable calcified plaque. Scores of 1 to 99 indicate mild calcification, 100 to 399 moderate, and 400 or above severe.
The predictive power of the CAC score is well established. Guidelines from the American College of Cardiology and American Heart Association drew on data from tens of thousands of asymptomatic patients to calculate the relative risk of major adverse cardiovascular events across different score ranges.4PubMed Central. Coronary Artery Calcium Scoring in Asymptomatic Patients A score of zero is particularly reassuring: it is associated with a very low risk of events over the next five to ten years, even in people who have some traditional risk factors. At the other end, a score above 400 signals substantial atherosclerotic burden and typically shifts treatment decisions toward more aggressive prevention.
Where CAC scoring is most useful is in that gray zone of intermediate risk, the person whose cholesterol, blood pressure, and family history put them somewhere between clearly low risk and clearly high risk. For that group, the calcium score often tips the decision about whether to start a statin or intensify lifestyle changes. A zero score in an intermediate-risk patient may justify holding off on medication, while a high score in the same person makes a strong argument for starting it.
The score does have blind spots. It detects only calcified plaque, not soft, lipid-rich plaque that has not yet calcified. A younger person with aggressive but early-stage atherosclerosis could have a zero score and still harbor dangerous non-calcified plaques. The test is most informative in middle-aged and older adults precisely because calcification has had time to develop and because the population data that define risk categories come overwhelmingly from that age group.
The Statin Paradox With Calcification
One of the more puzzling observations in cardiology is that statins, the drugs most reliably shown to reduce heart attacks and cardiovascular death, tend to increase coronary calcium scores over time. If calcium in your arteries is a marker of disease, why would a beneficial drug make that marker go up?
The answer lies in what statins do to the composition of plaque rather than its total size. Research using CT imaging to track plaque changes found that statin therapy shrank the volume of soft, lipid-rich plaque, the type most prone to rupture, while simultaneously increasing the volume of high-density calcified plaque.5JAMA Network. Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition The total amount of calcified plaque did not change much, but the calcium that was present became denser and more consolidated. In other words, statins appear to transform plaques from a vulnerable, soft state into a more stable, heavily calcified state.
This is a case where a rising number on a test does not mean the situation is getting worse. The calcium score goes up, but the risk of the plaque rupturing goes down. It is roughly analogous to a wound forming a hard scar: the scar tissue is not ideal, but it is a lot safer than an open wound. For patients already on statin therapy, a rising CAC score should not be interpreted as treatment failure. Clinicians who understand this distinction can avoid the trap of escalating treatment based on a number that is actually reflecting a favorable change in plaque biology.
Lifestyle Factors and Risk Reduction
No lifestyle intervention has been shown to reverse established coronary calcification. Once mineral deposits are in the artery wall, they stay there. What lifestyle changes can do is slow the rate at which new calcification develops, and more broadly, reduce the overall risk of a cardiovascular event regardless of what your calcium score says.
Exercise is one of the more interesting areas. Regular vigorous physical activity is unambiguously linked to lower cardiovascular mortality, yet some studies have found that highly active people, endurance athletes in particular, sometimes have higher CAC scores than sedentary peers. The leading interpretation is that exercise does not prevent calcification of existing plaques but does make those plaques more stable and improves all the other cardiovascular parameters (blood pressure, glucose control, inflammation, endothelial function) that determine whether a plaque becomes clinically dangerous. An athlete with a CAC score of 200 is not in the same risk category as a sedentary smoker with the same score.
Smoking cessation is perhaps the single most impactful modifiable factor. Smoking accelerates every step of the atherosclerotic process, from endothelial damage to inflammation to smooth muscle cell transformation. Quitting does not erase existing calcium, but it substantially slows the progression and reduces the inflammatory environment that makes existing plaques more likely to cause trouble. Dietary patterns rich in fruits, vegetables, and whole grains and low in processed food are associated with slower progression of atherosclerosis broadly, though isolating their specific effect on calcification from their effect on other plaque components is difficult.
Treating Heavily Calcified Arteries
When atherosclerotic calcification becomes severe enough to cause symptoms, whether through narrowing of the artery or by making the vessel wall so stiff that it cannot dilate properly, intervention may be needed. Heavy calcification creates a specific technical challenge for cardiologists: it makes it difficult to expand a stent fully against the artery wall. A stent that does not sit flush is more likely to clot or re-narrow over time.
Several tools have been developed specifically to deal with this problem. Rotational atherectomy uses a tiny diamond-tipped burr spinning at high speed to grind through calcium and create a channel for the stent. Orbital atherectomy works on a similar principle but uses an eccentric spinning crown that sands the calcium. Both are effective but require careful technique to avoid damaging the artery wall.
A newer approach, intravascular lithotripsy, borrows technology from the kidney stone world. A catheter delivers pulsed acoustic pressure waves, essentially tiny sonic booms, directly to the calcified segment of the artery. These waves fracture the calcium without damaging the surrounding soft tissue, improving vessel compliance and allowing a stent to be deployed properly.6Elsevier. Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease Intravascular lithotripsy has gained traction rapidly because it is relatively straightforward to use and appears to be effective against both superficial and deep calcium deposits, something the older atherectomy devices handle unevenly.
These interventional tools do not treat the underlying disease. They solve a mechanical problem, making room for a stent, in arteries where calcification has progressed to the point of causing symptoms or limiting blood flow. The ongoing management of atherosclerosis itself, through statins, blood pressure control, lifestyle changes, and managing conditions like diabetes and kidney disease, remains the foundation of long-term care regardless of whether an intervention has been performed.
When Calcium Shows Up Outside the Coronary Arteries
Coronary arteries get the most attention because of their direct link to heart attacks, but atherosclerotic calcification is a systemic process. The same calcium deposits can appear in the aorta, the carotid arteries supplying the brain, the arteries of the legs, and even the arteries feeding the kidneys. Aortic calcification, visible on a plain chest X-ray or abdominal CT, is extremely common in older adults and correlates with cardiovascular risk in much the same way coronary calcium does, though it is less precisely quantified.
Carotid calcification is routinely spotted on dental panoramic X-rays, sometimes catching both patients and dentists off guard. When calcification appears in the peripheral arteries of the legs, it can complicate the diagnosis and management of peripheral artery disease. Heavily calcified leg arteries give falsely elevated blood pressure readings when measured with a standard ankle cuff, because the stiff, calcified vessel does not compress normally. Clinicians managing peripheral artery disease in patients with diabetes or kidney disease, where leg artery calcification is especially common, have to account for this measurement artifact to avoid underestimating the severity of the blockage.
Calcification detected incidentally on imaging done for another reason, a CT scan of the abdomen for back pain, for instance, is increasingly recognized as a useful opportunistic finding. It offers a window into a person’s vascular health that was not the reason for the scan but may be more consequential than whatever prompted it. Whether and how aggressively to follow up on incidental vascular calcification depends on the patient’s age, existing risk factors, and whether they are already receiving appropriate preventive care.